Walleye Trading’s Juno Therapeutics, Inc. JUNO Stock Holding History

Walleye Trading’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,400	Closed	-$662	–	5025
2017 Q4	$662	Buy	14,400 +9,500	+194%	+$474K	﹤0.01%	2348
2017 Q3	$215	Buy	+4,900	New	+$167K	﹤0.01%	3174
2016 Q3	–	Sell	-800	Closed	-$31K	–	5808
2016 Q2	$31K	Sell	800 -100	-11%	-$4.15K	﹤0.01%	4311
2016 Q1	$35K	Buy	+900	New	+$31.4K	﹤0.01%	4129

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Walleye Trading's JUNO Position: Q2 2016 in Review

Walleye Trading sold out of Juno Therapeutics, Inc. (JUNO) in Q2 2016, closing a stake of 518 shares — an estimated $21.5K sold.

Walleye Trading first reported a position in JUNO in Q1 2016 and held it in 1 quarter. The position peaked at $20K in Q1 2016. 170 funds tracked by Wall St. Rank hold JUNO as of Q2 2016.

Walleye Trading reported no remaining Juno Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
Walleye Trading sold 518 Juno Therapeutics, Inc. shares in Q2 2016, an estimated $21.5K.
Walleye Trading first reported a position in Juno Therapeutics, Inc. in Q1 2016 and held it in 1 quarter.
Walleye Trading's Juno Therapeutics, Inc. position peaked at $20K in Q1 2016.
170 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q2 2016.

Based on Walleye Trading's 13F filing for Q2 2016, filed 15 Aug 2016.